TVAX Biomedical, LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From TVAX Biomedical, LLC
Financings Of The Fortnight: In The Aftermath Of Facebook IPO, Kythera Steps Up, TVAX And Cancer Genetics Back Off
Plus news on recent financing activity by TVM Capital, Royalty Pharma, Prosonix and Sangart.
Financings Of The Fortnight Considers The Value Of Insider Participation In Biotech IPOs
Plus news on recent financings by Radius Health, Cempra, Ironwood and Acetylon.
Deals Shaping The Medical Industry (12/2011)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.